Clinical Trial Update: Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD [Phase 3]

View source ↗

Summary

Phase 3 randomized pivotal trial evaluating ELAD for Acute Alcoholic Hepatitis was terminated, with results posted in January 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• ELAD (extracorporeal liver assist device)

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Acute Alcoholic Hepatitis | Phase 3 | Status: TERMINATED | Results posted: 2019-01-25